Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset still's disease

Macrophage activation syndrome (MAS) has been rarely reported in the course of adult-onset Still's disease (AOSD) and in the majority of cases, it was triggered by an infection. Here, we report, to our knowledge, the first case of MAS occurring after adalimumab treatment initiation and not trig...

Descripción completa

Detalles Bibliográficos
Autores principales: Souabni, Leila, Dridi, Leila, Abdelghani, Kawther Ben, Kassab, Selma, Chekili, Selma, Laater, Ahmed, Zakraoui, Leith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081143/
https://www.ncbi.nlm.nih.gov/pubmed/25018831
http://dx.doi.org/10.11604/pamj.2014.17.94.3386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081143/
https://www.ncbi.nlm.nih.gov/pubmed/25018831
http://dx.doi.org/10.11604/pamj.2014.17.94.3386

Ejemplares similares